- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 21.03. | Merck KGaA's MilliporeSigma drops €300M on Korean biologics plant with plans to create 300 new jobs | ||
| 21.03. | Catalent lays off 130 staffers at massive Indiana facility being sold to Novo Nordisk | ||
| 21.03. | BioTek reMEDys calls for awareness of safe bleeding disorder drug use | ||
| 21.03. | GSK joins AstraZeneca, Boehringer in capping US out-of-pocket inhaler prices at $35 per month | ||
| 21.03. | Despite positive trial, Roche says Enspryng fell short of expectations in myasthenia gravis | ||
| 21.03. | Merck's Lynparza-Keytruda combo sputters in 2nd lung cancer trial. Will an ADC pairing work instead? | ||
| 21.03. | Deerfield Agency adds BMS, AbbVie alum as head of media | ||
| 21.03. | As colorectal cancer patients get younger, governments need to boost awareness, screening: report | ||
| 21.03. | AstraZeneca enlists Walter the Dino to paint rivals as outdated | ||
| 20.03. | With exec appointments and new pharma unit, Bayer's overhaul takes shape | ||
| 20.03. | Idorsia's Tryvio crosses FDA finish line, offering new mechanism to treat hypertension | ||
| 20.03. | CDMO Lifecore Biomedical names new CEO, board chair after year-long strategic review | ||
| 20.03. | Lonza strikes $1.2B deal to buy mammoth Roche plant amid CDMO industry upheaval | ||
| 20.03. | BioNTech's shares tumble-again-amid continued COVID vaccine sales slide | ||
| 20.03. | Ad astra: Regeneron launches stargazing-themed campaign for high-dose Eylea | ||
| 20.03. | Orchard sets new gene therapy price tag at $4.25M-the steepest of any drug in the US | ||
| 20.03. | After Opdivo flop in liver cancer, Bristol Myers finds Yervoy combo could save lives | ||
| 20.03. | Qiagen teams with International Panel Physicians Association for tuberculosis screening awareness | ||
| 20.03. | Ted Danson cheers progress on psoriasis, teaming with BMS to help patients reach a good place | ||
| 19.03. | After monumental MASH nod, Madrigal plots $600M stock sale to support Rezdiffra launch | ||
| 19.03. | WuXi AppTec still sees sales growing and expansions rolling in 2024 despite concerns over US biosecurity bill | ||
| 19.03. | Takeda's Iclusig wins first-line FDA nod to treat rare Philadelphia chromosome-positive ALL | ||
| 19.03. | Oprah shines her star power on GLP-1s in new weight-loss drugs TV special | ||
| 19.03. | Gilead CEO Daniel O'Day collects 5% pay raise to $22.6M, his largest compensation package in years | ||
| 19.03. | Advocacy group activates Lung Force to push Congress for cash |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
